{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:24:51Z","timestamp":1761171891717,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.farma.2023.07.011","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T21:23:25Z","timestamp":1691011405000},"page":"289-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antiemetic prophylaxis in hematologic malignancies patients receiving conditioning protocols for hematopoietic stem cell transplantation: A study protocol for a systematic review"],"prefix":"10.1016","volume":"47","author":[{"given":"Nerea","family":"Ba\u00e9z-Gutierrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5810-1144","authenticated-orcid":false,"given":"Paloma","family":"Su\u00e1rez-Casillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7703-7045","authenticated-orcid":false,"given":"Maria Antonia","family":"P\u00e9rez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Bl\u00e1zquez-Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-3850","authenticated-orcid":false,"given":"Laila","family":"Abdelkader-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2023.07.011_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2015.12.001","article-title":"Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review","volume":"99","author":"Sommariva","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.farma.2023.07.011_bb0010","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/annonc\/mdv138","article-title":"Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review","volume":"26","author":"Jordan","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.farma.2023.07.011_bb0015","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.1188\/12.CJON.E133-E141","article-title":"Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting","volume":"16","author":"Viale","year":"2012","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.farma.2023.07.011_bb0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00277-020-03945-3","article-title":"Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs","volume":"99","author":"Pastore","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.farma.2023.07.011_bb0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1188\/15.CJON.438-443","article-title":"Delayed chemotherapy-induced nausea and vomiting in the hematology population: a review of the literature","volume":"19","author":"Gonella","year":"2015","journal-title":"CJON."},{"key":"10.1016\/j.farma.2023.07.011_bb0030","first-page":"2911","article-title":"Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors","volume":"26","author":"Puri","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.farma.2023.07.011_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.critrevonc.2017.02.017","article-title":"Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis","volume":"112","author":"Yoodee","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.farma.2023.07.011_bb0040","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","article-title":"Incidence of chemotherapy-induced nausea and emesis after modern antiemetics: perception versus reality","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer."},{"key":"10.1016\/j.farma.2023.07.011_bb0045","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1200\/JCO.20.01296","article-title":"Antiemetics: ASCO guideline update","volume":"38","author":"Hesketh","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.farma.2023.07.011_bb0050","first-page":"8097","article-title":"MASCC antiemetics in advanced cancer updated guideline","volume":"29","author":"Davis","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.farma.2023.07.011_bb0055","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.farma.2023.07.011_bb0060","doi-asserted-by":"crossref","first-page":"883","DOI":"10.6004\/jnccn.2017.0117","article-title":"NCCN guidelines insights: antiemesis, version 2.2017","volume":"15","author":"Berger","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.farma.2023.07.011_bb0065","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Hesketh","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.farma.2023.07.011_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s44228-022-00012-8","article-title":"Antiemetic strategies in patients who undergo hematopoietic stem cell transplantation","volume":"4","author":"Yuda","year":"2022","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.farma.2023.07.011_bb0075","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ."},{"key":"10.1016\/j.farma.2023.07.011_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.farma.2023.07.011_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/apt.16386","article-title":"Review article: the evolution of endpoint assessments for chemotherapy-induced nausea and vomiting and post-operative nausea and vomiting-a perspective from the US Food and Drug Administration","volume":"54","author":"Gabby","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.farma.2023.07.011_bb0090","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1097\/NCC.0b013e3181e2cd79","article-title":"Tools for assessing nausea, vomiting, and retching","volume":"34","author":"Wood","year":"2011","journal-title":"Cancer Nurs"},{"author":"Higgins","key":"10.1016\/j.farma.2023.07.011_bb0095"},{"key":"10.1016\/j.farma.2023.07.011_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2299","article-title":"Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols","volume":"337","author":"Chan","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.farma.2023.07.011_bb0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jclinepi.2017.07.010","article-title":"Comparison between publicly accessible publications, registries, and protocols of phase III trials indicated persistence of selective outcome reporting","volume":"91","author":"Zhang","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634323001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634323001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:18:05Z","timestamp":1761106685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634323001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1130634323001010"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2023.07.011","relation":{},"ISSN":["1130-6343"],"issn-type":[{"type":"print","value":"1130-6343"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiemetic prophylaxis in hematologic malignancies patients receiving conditioning protocols for hematopoietic stem cell transplantation: A study protocol for a systematic review","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2023.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}